Cytokine production by cryopreserved human peripheral blood mononuclear cells in response to periodontal pathogens. 1998

T Canaan, and M M D'Alesandro, and G A Miller
Research Department, Naval Dental School, National Naval Dental Center, Bethesda, MD, USA.

Freezing techniques provide a way of repeating and extending immunological assays by using frozen portions of an individual's peripheral blood mononuclear cell fraction. Earlier work shows that the lymphocytes that are stored frozen retain their ability to respond to polyclonal B-cell activators, mitogens, superantigens and bacterial extracts of oral interest. These studies extend previous findings by determining cytokine production by lymphocytes following frozen storage for up to 24 weeks. Production of interleukin (IL)-1beta, IL-2, IL-6, and tumour necrosis factor (TNF)-beta by stimulated lymphocytes after cyropreservation was not significantly different from those responses before storage, with one exception: IL-6 production was negligible after 24 weeks' frozen storage when thawed cells were cocultured with pokeweed mitogen. After stimulation with extracts from Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans, the proliferative capacity of the frozen cells was maintained as well as the production of IL-1beta, IL-2, and IL-6. TNF-beta was not produced in response to bacterial antigen stimulation. The ability of peripheral blood mononuclear cells to retain functional activity after frozen storage should permit more effective monitoring during longitudinal clinical studies and a better evaluation of changes in cytokine production in patients with advanced periodontitis both during and after treatment.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

T Canaan, and M M D'Alesandro, and G A Miller
August 1996, The Journal of infectious diseases,
T Canaan, and M M D'Alesandro, and G A Miller
March 2012, Genetics and molecular research : GMR,
T Canaan, and M M D'Alesandro, and G A Miller
November 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
T Canaan, and M M D'Alesandro, and G A Miller
January 2002, Amino acids,
T Canaan, and M M D'Alesandro, and G A Miller
October 2004, Cytokine,
T Canaan, and M M D'Alesandro, and G A Miller
August 1991, Clinical and experimental immunology,
T Canaan, and M M D'Alesandro, and G A Miller
November 2006, Journal of pharmacological sciences,
T Canaan, and M M D'Alesandro, and G A Miller
January 1991, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!